Skip to content

Gyre Therapeutics, Inc. GYRE Payments to Acquire Intangible Assets

Payments to Acquire Intangible Assets at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Innoviva, Inc. logo
Innoviva, Inc.INVA
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s payments to acquire intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s payments to acquire intangible assets?
Gyre Therapeutics, Inc. (GYRE) reported payments to acquire intangible assets of $5K in Q1 2026.
How has Gyre Therapeutics, Inc.'s payments to acquire intangible assets changed year-over-year?
Gyre Therapeutics, Inc.'s payments to acquire intangible assets decreased by 99.3% year-over-year, from $699K to $5K.
What is the long-term trend for Gyre Therapeutics, Inc.'s payments to acquire intangible assets?
Over 2 years (2022 to 2025), Gyre Therapeutics, Inc.'s payments to acquire intangible assets has grown at a 652.9% compound annual growth rate (CAGR), from $13K to $737K.